Vanta Bioscience

Vanta Bioscience EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vanta Bioscience (540729.BO) as of Oct 18, 2026 is -42.57 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 13.13 M INR — a change of -424.22% (lower).

EBITDA

-42.57 MINR

YoY

-424.22%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vanta Bioscience is 2025 -42.57 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vanta Bioscience was 2024 13.13 M INR. It decreases by -424.22% lower compared to the previous year.

The Vanta Bioscience EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
10.31 M INR
Jan 1, 2019
37.34 M INR
Jan 1, 2020
43.69 M INR
Jan 1, 2021
39.99 M INR
Jan 1, 2022
34.68 M INR
Jan 1, 2023
-23.94 M INR
Jan 1, 2024
13.13 M INR
Jan 1, 2025
-42.57 M INR
The Vanta Bioscience EBITDA history
YEAREBITDAYoY
-42.57 MINR-424.22%
13.13 MINR-154.84%
-23.94 MINR-169.02%
34.68 MINR-13.28%
39.99 MINR-8.46%
43.69 MINR+17.00%
37.34 MINR+262.26%
10.31 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vanta Bioscience Stock analysis

What does Vanta Bioscience do? Vanta Bioscience Ltd is a company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Secunderabad, India, the company provides preclinical contract research services. It went public through an IPO on October 6, 2017. Vanta Bioscience offers a range of services including testing and contract research in clinical research, pre-clinical research, biopharma services, analytical testing, and environmental studies. The company serves clients from various industries such as pharmaceuticals, medical devices, nutraceuticals, feed additives, biotechnology, agrochemicals, cosmetics, and chemicals. Their services include preclinical safety assessment, risk assessment for active pharmaceutical ingredients (APIs), excipients, extractables and leachables, and pharmaceutical impurities. Additionally, Vanta Bioscience provides services for determining health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), as well as occupational exposure limits (OEL) for pharmaceutical manufacturers. The company's website is www.vantabio.com. Vanta Bioscience Ltd is listed on the Bombay Stock Exchange under the ticker 540729.BO and has the ISIN INE695X01011. The company focuses on delivering comprehensive preclinical research solutions to support the development and safety evaluation of products across multiple sectors. Vanta Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vanta Bioscience stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vanta Bioscience is -42.57 M INR in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vanta Bioscience changed from 13.13 M INR to -42.57 M INR, representing a -424.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Vanta Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Vanta Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vanta Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vanta Bioscience